Skip to main content

01.01.2014 | Original Paper

High-incidence spontaneous tumors in JF1/Ms mice: relevance of hypomorphic germline mutation and subsequent promoter methylation of Ednrb

verfasst von: Junko Watanabe, Yasuhiko Kaneko, Masafumi Kurosumi, Yasuhito Kobayashi, Michihiro Sakamoto, Mitsuaki A. Yoshida, Miho Akiyama, Yoshibumi Matsushima

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

JF1/Ms mice, an inbred strain derived from Japanese wild mice, carry a germline hypomorphic mutation in the endothelin receptor type B gene (Ednrb). We observed that the JF1/Ms mice develop various spontaneous tumors at a high incidence late in life. The aim of this study was to elucidate the mechanism responsible for spontaneous tumors in these mice. Possible relevance of milk-borne mammary tumor virus and gene alterations in Ednrb to tumorigenesis was explored.

Methods

Expression and methylation status of Ednrb were quantitatively analyzed in normal and cancer tissues of mammary gland, liver, submandibular gland as well as in a cultured cell line, MW1, established from a submandibular gland adenocarcinoma. The biological effects of EDNRB were examined in the MW1 cells transfected with wild-type Ednrb.

Results

Transcripts of Ednrb were barely detectable, and the promoter region of Ednrb was hypermethylated in tumor tissues and the MW1 cells. In contrast, normal counterpart tissues showed positive expression of Ednrb transcripts and had unmethylated promoter regions. Treatment of the MW1 cells with 5-Aza-dC restored transcription of Ednrb to normal levels. Transfection of the MW1 cells with Ednrb1 (MW1-Ednrb1) resulted in lower growth rates and morphological changes compared with the mock-transfected MW1 cells (MW1-mock1). Furthermore, the MW1-Ednrb1 cells transplanted in syngeneic mice showed a lower proliferation rate than the MW1-mock1 cells.

Conclusions

Germline mutation and subsequent promoter methylation of Ednrb may be relevant to cancer susceptibility in the JF1/Ms mice. These data indicate that Ednrb acts as a tumor suppressor, as reported in human prostate, bladder, and clear cell renal carcinomas.
Literatur
Zurück zum Zitat Bagnato A, Rosano L, Spinella F, Castro VD, Tecce R, Natali PG (2004) Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression. Cancer Res 64:1436–1443PubMedCrossRef Bagnato A, Rosano L, Spinella F, Castro VD, Tecce R, Natali PG (2004) Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression. Cancer Res 64:1436–1443PubMedCrossRef
Zurück zum Zitat Bittner M, Meltzer P, Chen Y, Jiang Y, Settor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Sampas N, Dougherty E et al (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406:536–540PubMedCrossRef Bittner M, Meltzer P, Chen Y, Jiang Y, Settor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Sampas N, Dougherty E et al (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406:536–540PubMedCrossRef
Zurück zum Zitat Demokan S, Chang X, Chuang A, Mydlarz WK, Kaur J, Huang P, Khan Z, Khan T, Ostrow KL, Brait M, Hoque MO, Legeois NJ (2010) KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses. Int J Cancer 127:2351–2359PubMedCentralPubMedCrossRef Demokan S, Chang X, Chuang A, Mydlarz WK, Kaur J, Huang P, Khan Z, Khan T, Ostrow KL, Brait M, Hoque MO, Legeois NJ (2010) KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses. Int J Cancer 127:2351–2359PubMedCentralPubMedCrossRef
Zurück zum Zitat Demunter A, Wolf-Peeters CD, Degreet H, Stas M, Van den Oord JJ (2001) Expression of endothelin-B receptor in pigmented cell lesions of the skin: evidence for its role as tumor progression marker in malignant melanoma. Virchows Arch 438:485–491PubMedCrossRef Demunter A, Wolf-Peeters CD, Degreet H, Stas M, Van den Oord JJ (2001) Expression of endothelin-B receptor in pigmented cell lesions of the skin: evidence for its role as tumor progression marker in malignant melanoma. Virchows Arch 438:485–491PubMedCrossRef
Zurück zum Zitat Eltze E, Bertolin M, Korsching E, Wulfing P, Maggino T, Lelle R (2007) Expression and prognostic relevance of endothelin-B receptor in vulvar cancer. Oncol Rep 18:305–311PubMed Eltze E, Bertolin M, Korsching E, Wulfing P, Maggino T, Lelle R (2007) Expression and prognostic relevance of endothelin-B receptor in vulvar cancer. Oncol Rep 18:305–311PubMed
Zurück zum Zitat Hyytinen ER, Frierson HF Jr, Boyd JC, Chung LWK, Dong JT (1999) Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer. Genes Chromosomes Cancer 25:108–114PubMedCrossRef Hyytinen ER, Frierson HF Jr, Boyd JC, Chung LWK, Dong JT (1999) Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer. Genes Chromosomes Cancer 25:108–114PubMedCrossRef
Zurück zum Zitat Koide T, Moriwaki K, Uchida K, Mita A, Sagai T, Yonekawa H, Katoh H, Miyashita N, Tsuchiya K, Nielsen TJ, Shiroishi T (1998) A new inbred strain JF1 established from Japanese fancy mouse carrying the classic piebald allele. Mamm Genome 9:15–19PubMedCrossRef Koide T, Moriwaki K, Uchida K, Mita A, Sagai T, Yonekawa H, Katoh H, Miyashita N, Tsuchiya K, Nielsen TJ, Shiroishi T (1998) A new inbred strain JF1 established from Japanese fancy mouse carrying the classic piebald allele. Mamm Genome 9:15–19PubMedCrossRef
Zurück zum Zitat Koon HB, Ippolito GC, Banham AH, Tucker PW (2007) FOXP1: a potential therapeutic target in cancer. Expert Opin Ther Targets 11:955–965PubMedCrossRef Koon HB, Ippolito GC, Banham AH, Tucker PW (2007) FOXP1: a potential therapeutic target in cancer. Expert Opin Ther Targets 11:955–965PubMedCrossRef
Zurück zum Zitat Lahav R, Suva ML, Rimoldi D, Patterson PH, Stamenkovic I (2004) Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanomas. Cancer Res 64:8945–8953PubMedCrossRef Lahav R, Suva ML, Rimoldi D, Patterson PH, Stamenkovic I (2004) Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanomas. Cancer Res 64:8945–8953PubMedCrossRef
Zurück zum Zitat Lo KW, Tsang YS, Kwong J, To KF, Teo PML, Huang DP (2002) Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma. Int J Cancer 98:651–655PubMedCrossRef Lo KW, Tsang YS, Kwong J, To KF, Teo PML, Huang DP (2002) Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma. Int J Cancer 98:651–655PubMedCrossRef
Zurück zum Zitat Matsushima Y, Shinkai Y, Kobayashi Y, Sakamoto M, Kunieda T, Tachibana M (2002) A mouse model of Waardenburg syndrome type 4 with a new spontaneous mutation of the endothelin-B receptor gene. Mamm Genome 13:30–35PubMedCrossRef Matsushima Y, Shinkai Y, Kobayashi Y, Sakamoto M, Kunieda T, Tachibana M (2002) A mouse model of Waardenburg syndrome type 4 with a new spontaneous mutation of the endothelin-B receptor gene. Mamm Genome 13:30–35PubMedCrossRef
Zurück zum Zitat Moriwaki K, Miyashita N, Yamaguchi Y, Siroishi T (1999) Multiple genes governing biological function in the genetic backgrounds of laboratory mice and Asian wild mice. Prog Exp Tumor Res 35:1–12PubMedCrossRef Moriwaki K, Miyashita N, Yamaguchi Y, Siroishi T (1999) Multiple genes governing biological function in the genetic backgrounds of laboratory mice and Asian wild mice. Prog Exp Tumor Res 35:1–12PubMedCrossRef
Zurück zum Zitat Nelson JB, Lee WH, Nguyen SH, Jarrard DF, Brooks JD, Magnuson SR, Opgenorth TJ, Nelson WG, Bova GS (1997) Methylation of the 5′ CpG island of the endothelin B receptor genes is common in human prostate cancer. Cancer Res 57:35–37PubMed Nelson JB, Lee WH, Nguyen SH, Jarrard DF, Brooks JD, Magnuson SR, Opgenorth TJ, Nelson WG, Bova GS (1997) Methylation of the 5′ CpG island of the endothelin B receptor genes is common in human prostate cancer. Cancer Res 57:35–37PubMed
Zurück zum Zitat Ohtani S, Shinkai Y, Horibe A, Katayama K, Tsuji T, Matsushima Y, Tachibana M, Kunieda T (2006) A deletion in the Endothelin-B receptor gene is responsible for the Waardenburg syndrome-like phenotypes of WS4 mice. Exp Anim 55:491–495PubMedCrossRef Ohtani S, Shinkai Y, Horibe A, Katayama K, Tsuji T, Matsushima Y, Tachibana M, Kunieda T (2006) A deletion in the Endothelin-B receptor gene is responsible for the Waardenburg syndrome-like phenotypes of WS4 mice. Exp Anim 55:491–495PubMedCrossRef
Zurück zum Zitat Okamoto M, Yonekawa H (2005) Intestinal tumorigenesis in Min mice is enhanced by X-irradiation in an age-dependent manner. J Radiat Res 46:83–91PubMedCrossRef Okamoto M, Yonekawa H (2005) Intestinal tumorigenesis in Min mice is enhanced by X-irradiation in an age-dependent manner. J Radiat Res 46:83–91PubMedCrossRef
Zurück zum Zitat Okumoto M, Mori N, Miyashita N, Moriwaki K, Imai S, Haga S, Hiroishi S, Takamori Y, Esaki K (1995) Radiation-induced lymphomas in MSM, (BALB/cHeA x MSM) F1 and (BALB/cHeA x STS/A) F1 hybrid mice. Exp Anim 44:43–48PubMedCrossRef Okumoto M, Mori N, Miyashita N, Moriwaki K, Imai S, Haga S, Hiroishi S, Takamori Y, Esaki K (1995) Radiation-induced lymphomas in MSM, (BALB/cHeA x MSM) F1 and (BALB/cHeA x STS/A) F1 hybrid mice. Exp Anim 44:43–48PubMedCrossRef
Zurück zum Zitat Pla P, Larue L (2003) Involvement of endothelin receptors in normal and pathological development of neural crest cells. Int J Dev Biol 47:315–325PubMed Pla P, Larue L (2003) Involvement of endothelin receptors in normal and pathological development of neural crest cells. Int J Dev Biol 47:315–325PubMed
Zurück zum Zitat Smith SL, Damato BE, Scholes AGM, Nunn J, Field JK, Heighway J (2002) Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival. Br J Cancer 87:1308–1313PubMedCentralPubMedCrossRef Smith SL, Damato BE, Scholes AGM, Nunn J, Field JK, Heighway J (2002) Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival. Br J Cancer 87:1308–1313PubMedCentralPubMedCrossRef
Zurück zum Zitat Takizawa T, Nakashima K, Namihira M, Ochiai W, Uemura A, Yanagisawa M, Fujita N, Nakao M, Taga T (2001) DNA methylation is a critical cell-intrinsic determinant of astrocyte differentiation in the fetal brain. Dev Cell 1:749–758PubMedCrossRef Takizawa T, Nakashima K, Namihira M, Ochiai W, Uemura A, Yanagisawa M, Fujita N, Nakao M, Taga T (2001) DNA methylation is a critical cell-intrinsic determinant of astrocyte differentiation in the fetal brain. Dev Cell 1:749–758PubMedCrossRef
Zurück zum Zitat Yamada T, Ohtani S, Sakurai T, Tsujii T, Kunieda T, Yanagisawa M (2006) Reduced expression of the endothelin receptor type B gene in piebalt mice caused by insertion of a retroposon-like element in intron1. J Biol Chem 281:10799–10807PubMedCrossRef Yamada T, Ohtani S, Sakurai T, Tsujii T, Kunieda T, Yanagisawa M (2006) Reduced expression of the endothelin receptor type B gene in piebalt mice caused by insertion of a retroposon-like element in intron1. J Biol Chem 281:10799–10807PubMedCrossRef
Zurück zum Zitat Yao M, Huang Y, Shioi K, Hattori K, Murakami T, Sano F, Baba M, Kondo K, Nakaigawa N, Kishida T, Nagashima Y, Yamada-Okabe H et al (2008) A three-gene expression signature model to predict clinical outcome of clear cell renal carcinoma. Int J Cancer 123:1126–1132PubMedCrossRef Yao M, Huang Y, Shioi K, Hattori K, Murakami T, Sano F, Baba M, Kondo K, Nakaigawa N, Kishida T, Nagashima Y, Yamada-Okabe H et al (2008) A three-gene expression signature model to predict clinical outcome of clear cell renal carcinoma. Int J Cancer 123:1126–1132PubMedCrossRef
Zurück zum Zitat Yates DR, Rehman I, Abbod MF, Meuth M, Cross SS, Linkens DA, Hamdy FC, Catto JWF (2007) Promoter hypermethylation identifies progression risk in bladder cancer. Clin Cancer Res 13:2046–2053PubMedCrossRef Yates DR, Rehman I, Abbod MF, Meuth M, Cross SS, Linkens DA, Hamdy FC, Catto JWF (2007) Promoter hypermethylation identifies progression risk in bladder cancer. Clin Cancer Res 13:2046–2053PubMedCrossRef
Zurück zum Zitat Yegnasubramanian S, Kowalski J, Gonzalgo ML, Zahurak M, Piantadosi S, Walsh PC, Bova GS, Marzo AMD, Isaacs WB, Nelson WG (2004) Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res 64:1975–1986PubMedCrossRef Yegnasubramanian S, Kowalski J, Gonzalgo ML, Zahurak M, Piantadosi S, Walsh PC, Bova GS, Marzo AMD, Isaacs WB, Nelson WG (2004) Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res 64:1975–1986PubMedCrossRef
Zurück zum Zitat Zhao BJ, Sun DG, Zhang M, Tan SN, Ma X (2009) Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma. Dis Esophagus 22:55–61PubMedCrossRef Zhao BJ, Sun DG, Zhang M, Tan SN, Ma X (2009) Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma. Dis Esophagus 22:55–61PubMedCrossRef
Zurück zum Zitat Zhou L, Feng X, Shan W, Zhou W, Liu W, Zhu B, Yi H, Yao K, Ren C (2007) Alterations of the EDNRB gene in nasopharyngeal carcinoma. Oncology 72:357–363PubMedCrossRef Zhou L, Feng X, Shan W, Zhou W, Liu W, Zhu B, Yi H, Yao K, Ren C (2007) Alterations of the EDNRB gene in nasopharyngeal carcinoma. Oncology 72:357–363PubMedCrossRef
Metadaten
Titel
High-incidence spontaneous tumors in JF1/Ms mice: relevance of hypomorphic germline mutation and subsequent promoter methylation of Ednrb
verfasst von
Junko Watanabe
Yasuhiko Kaneko
Masafumi Kurosumi
Yasuhito Kobayashi
Michihiro Sakamoto
Mitsuaki A. Yoshida
Miho Akiyama
Yoshibumi Matsushima
Publikationsdatum
01.01.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 1/2014
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-013-1546-6

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.